Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01436799
Other study ID # GIRBA2466
Secondary ID
Status Completed
Phase N/A
First received September 15, 2011
Last updated August 25, 2013
Start date March 2011
Est. completion date August 2011

Study information

Verified date August 2013
Source Gachon University Gil Medical Center
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators hypothesized that both propofol and desflurane would decrease the regional oxygen saturation (rSO2) but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position.


Description:

The investigators hypothesized that both propofol and desflurane would decrease the rSO2 but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position. Therefore, the purpose of this study was to investigate the effect of desflurane and propofol on rSO2 values during the beach chair position for shoulder arthroscopy.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- Forty patients,

- ASA class I or II,

- undergoing shoulder arthroscopy

Exclusion Criteria:

- Patients with history of cerebrovascular disease, coronary occlusive disease and/or obesity (body mass index > 30) were excluded from this study.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
propofol
anaesthesia was induced with the effect-site concentration of propofol 5.0 µg ml-1 mainly.
Desflurane
anaesthesia was maintained by desflurane 4-7vol%
alfentanil
administration of alfentanil 10 µg kg-1 for anesthetic induction
Rocuronium
administration of rocuronium 0.6 mg kg-1 for anesthetic induction

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Gachon University Gil Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Regional Cerebral Oxygen Satuation (rSO2) definitive values of regional cerebral oxygen saturation(rSO2,%) values are described as mean (SD) 1, 3, 5, 7, and 9 min after the beach chair position Yes
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT04167527 - Endovascular Therapy for Low NIHSS Ischemic Strokes Phase 2/Phase 3
Recruiting NCT04583163 - Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Completed NCT01436812 - Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy N/A
Terminated NCT00141011 - Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Recruiting NCT05053932 - Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
Completed NCT04437862 - A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke N/A
Completed NCT00598819 - A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers Phase 1
Completed NCT00207961 - The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia N/A
Not yet recruiting NCT04696523 - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Phase 2
Completed NCT02351518 - Cerebral Autoregulation and Vasospasm in Patients With TBI
Completed NCT01546636 - The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position N/A
Completed NCT04047563 - Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke Phase 3
Completed NCT05087836 - Correlation of Cerebral Oxygen Saturation Measured From 2 Sensor Sites: Forehead vs. Temporal
Completed NCT02448069 - Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke Phase 2
Completed NCT02147275 - Monitoring Hypertensive Patients's Cerebral Oxygen Saturation N/A
Completed NCT01875055 - Reversing Cerebral Oxygen Desaturations Greater That 10% of Baseline Values Using NIRS in the ICU N/A
Completed NCT02389647 - Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury
Completed NCT02643030 - Hypercapnia During Shoulder Arthroscopy N/A
Terminated NCT01312623 - Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease N/A